Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1989;9:1-20

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wight, T. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wight, T. N.

Arteriosclerosis, Vol 9, 1-20, Copyright © 1989 by American Heart Association


ARTICLES

Cell biology of arterial proteoglycans

TN Wight
Department of Pathology, University of Washington, School of Medicine, Seattle 98195.

Although proteoglycans constitute a minor component of vascular tissue, these molecules have been shown to influence a number of arterial properties such as viscoelasticity, permeability, lipid metabolism, hemostasis, and thrombosis. A hallmark of early and late atherosclerosis is the accumulation of proteoglycans in the intimal lesions. Yet, it is not clear why this accumulation occurs. This article reviews the classes of proteoglycans synthesized by the two major cell types of the arterial wall--the endothelial and smooth muscle cell. Detailed consideration is then given to the modulation of proteoglycan metabolism and the role that proteoglycans play in a number of cellular events such as adhesion, migration, and proliferation--important processes in both the development and the pathogenesis of blood vessels. Last, the involvement of proteoglycans in two critical vascular wall processes--hemostasis and lipid metabolism--is reviewed, because these events pertain to atherogenesis. This review emphasizes the importance of proteoglycans in regulating several key events in normal and pathophysiological processes in the vascular tissue.


This article has been cited by other articles:


Home page
Reproductive SciencesHome page
O. Khorram, M. Momeni, M. Desai, and M. G. Ross
Nutrient Restriction In Utero Induces Remodeling of the Vascular Extracellular Matrix in Rat Offspring
Reproductive Sciences, January 1, 2007; 14(1): 73 - 80.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. D. O'Brien
Pathogenesis of Calcific Aortic Valve Disease: A Disease Process Comes of Age (and a Good Deal More)
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1721 - 1728.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-S. Zheng, M. Reis, C. Sparling, D. Y. Lee, D. P. La Pierre, C.-K. A. Wong, Z. Deng, S. Kahai, J. Wen, and B. B. Yang
Versican G3 Domain Promotes Blood Coagulation through Suppressing the Activity of Tissue Factor Pathway Inhibitor-1
J. Biol. Chem., March 24, 2006; 281(12): 8175 - 8182.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
X. Zeng, J. Chen, Y. I. Miller, K. Javaherian, and K. S. Moulton
Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis
J. Lipid Res., September 1, 2005; 46(9): 1849 - 1859.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P.-S. Zheng, D. Vais, D. LaPierre, Y.-Y. Liang, V. Lee, B. L. Yang, and B. B. Yang
PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation
J. Cell Sci., November 15, 2004; 117(24): 5887 - 5895.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Farb, F. D. Kolodgie, J.-Y. Hwang, A. P. Burke, K. Tefera, D. K. Weber, T. N. Wight, and R. Virmani
Extracellular Matrix Changes in Stented Human Coronary Arteries
Circulation, August 24, 2004; 110(8): 940 - 947.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Schmidt, S. Geigenmueller, W. Voelker, P. Seiler, and E. Buddecke
Exogenous nitric oxide causes overexpression of TGF-{beta}1 and overproduction of extracellular matrix in human coronary smooth muscle cells
Cardiovasc Res, June 1, 2003; 58(3): 671 - 678.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
I. GOUNI-BERTHOLD and A. SACHINIDIS
Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?
FASEB J, October 1, 2002; 16(12): 1477 - 1487.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. V. Sakharov, A. F. H. Jie, M. E. A. Bekkers, J. J. Emeis, and D. C. Rijken
Polylysine as a Vehicle for Extracellular Matrix-Targeted Local Drug Delivery, Providing High Accumulation and Long-Term Retention Within the Vascular Wall
Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 943 - 948.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
O. N. El-Assal, A. Yamanoi, T. Ono, H. Kohno, and N. Nagasue
The Clinicopathological Significance of Heparanase and Basic Fibroblast Growth Factor Expressions in Hepatocellular Carcinoma
Clin. Cancer Res., May 1, 2001; 7(5): 1299 - 1305.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
Y. Friedmann, I. Vlodavsky, H. Aingorn, A. Aviv, T. Peretz, I. Pecker, and O. Pappo
Expression of Heparanase in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa and Stroma : Evidence for Its Role in Colonic Tumorigenesis
Am. J. Pathol., October 1, 2000; 157(4): 1167 - 1175.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. VENKATESAN, T. EBIHARA, P. J. ROUGHLEY, and M. S. LUDWIG
Alterations in Large and Small Proteoglycans in Bleomycin-Induced Pulmonary Fibrosis in Rats
Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 2066 - 2073.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Orlandi, M. Marcellini, and L. G. Spagnoli
Aging Influences Development and Progression of Early Aortic Atherosclerotic Lesions in Cholesterol-Fed Rabbits
Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1123 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. C. van der Wal and A. E. Becker
Atherosclerotic plaque rupture - pathologic basis of plaque stability and instability
Cardiovasc Res, February 1, 1999; 41(2): 334 - 344.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. C Newby and A. B Zaltsman
Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation
Cardiovasc Res, February 1, 1999; 41(2): 345 - 360.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. D. O'Brien, K. L. Olin, C. E. Alpers, W. Chiu, M. Ferguson, K. Hudkins, T. N. Wight, and A. Chait
Comparison of Apolipoprotein and Proteoglycan Deposits in Human Coronary Atherosclerotic Plaques : Colocalization of Biglycan With Apolipoproteins
Circulation, August 11, 1998; 98(6): 519 - 527.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
P. K Shah
Role of inflammation and metalloproteinases in plaque disruption and thrombosis
Vascular Medicine, August 1, 1998; 3(3): 199 - 206.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. Y. Chang, K. L. Olin, C. Tsoi, T. N. Wight, and A. Chait
Human Monocyte-derived Macrophages Secrete Two Forms of Proteoglycan-Macrophage Colony-stimulating Factor That Differ in Their Ability to Bind Low Density Lipoproteins
J. Biol. Chem., June 26, 1998; 273(26): 15985 - 15992.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. M. F. Tovar, D. C. F. Cesar, G. C. Leta, and P. A. S. Mourao
Age-Related Changes in Populations of Aortic Glycosaminoglycans : Species With Low Affinity for Plasma Low-Density Lipoproteins, and Not Species With High Affinity, Are Preferentially Affected
Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 604 - 614.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Kinsella, C. K. Tsoi, H. T. Jarvelainen, and T. N. Wight
Selective Expression and Processing of Biglycan during Migration of Bovine Aortic Endothelial Cells. THE ROLE OF ENDOGENOUS BASIC FIBROBLAST GROWTH FACTOR
J. Biol. Chem., January 3, 1997; 272(1): 318 - 325.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Sartipy, B. Johansen, G. Camejo, B. Rosengren, G. Bondjers, and E. Hurt-Camejo
Binding of Human Phospholipase A2 Type II to Proteoglycans. DIFFERENTIAL EFFECT OF GLYCOSAMINOGLYCANS ON ENZYME ACTIVITY
J. Biol. Chem., October 18, 1996; 271(42): 26307 - 26314.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, S. Chiu Wong, M. K. Hong, J. A. Kovach, and M. B. Leon
Arterial Remodeling After Coronary Angioplasty : A Serial Intravascular Ultrasound Study
Circulation, July 1, 1996; 94(1): 35 - 43.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. M. Lemire, S. Potter-Perigo, K. L. Hall, T. N. Wight, and S. M. Schwartz
Distinct Rat Aortic Smooth Muscle Cells Differ in Versican/PG-M Expression
Arterioscler. Thromb. Vasc. Biol., June 1, 1996; 16(6): 821 - 829.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. D. O'Brien, D. D. Reichenbach, S. M. Marcovina, J. Kuusisto, C. E. Alpers, and C. M. Otto
Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of `Degenerative' Valvular Aortic Stenosis
Arterioscler. Thromb. Vasc. Biol., April 1, 1996; 16(4): 523 - 532.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Farb, A. P. Burke, A. L. Tang, Y. Liang, P. Mannan, J. Smialek, and R. Virmani
Coronary Plaque Erosion Without Rupture Into a Lipid Core : A Frequent Cause of Coronary Thrombosis in Sudden Coronary Death
Circulation, April 1, 1996; 93(7): 1354 - 1363.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. Sivaram, J. C. Obunike, and I. J. Goldberg
Lysolecithin-induced Alteration of Subendothelial Heparan Sulfate Proteoglycans Increases Monocyte Binding to Matrix
J. Biol. Chem., December 15, 1995; 270(50): 29760 - 29765.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. G. Steg, M. Ziol, O. Tahlil, C. Robert, P. Masson, D. Pruneau, P. Bruneval, and P. Belichard
Reduction of Intimal Hyperplasia by Naroparcil, a 4-Methylumbelliferyl ß-D-Xyloside Analogue, After Arterial Injury in the Hypercholesterolemic Rabbit
Circ. Res., November 1, 1995; 77(5): 919 - 926.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. H. Camejo, B. Rosengren, G. Camejo, P. Sartipy, G. Fager, and G. Bondjers
Interferon Gamma Binds to Extracellular Matrix Chondroitin-Sulfate Proteoglycans, Thus Enhancing Its Cellular Response
Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1456 - 1465.
[Abstract] [Full Text]


Home page
CirculationHome page
E. Falk, P. K. Shah, and V. Fuster
Coronary Plaque Disruption
Circulation, August 1, 1995; 92(3): 657 - 671.
[Full Text]


Home page
CirculationHome page
W. Casscells
Growth Factor Therapies for Vascular Injury and Ischemia
Circulation, June 1, 1995; 91(11): 2699 - 2702.
[Full Text]


Home page
ANGIOLOGYHome page
A. Calabro, F. Piarulli, D. Milan, A. Rossi, G. Coscetti, and G. Crepaldi
Clinical Assessment of Low Molecular Weight Heparin Effects in Peripheral Vascular Disease
Angiology, March 1, 1993; 44(3): 188 - 195.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
Y. Nakashima, J. Segawa, T. Kawashima, Y. Fukuchi, and A. Kuroiwa
Chronic Arterial Occlusion with PGE1-Resistant Skin Lesions Treated by Glycosaminoglycan Compound Case Reports
Angiology, September 1, 1990; 41(9): 731 - 736.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
R. T. Lee, C. Yamamoto, Y. Feng, S. Potter-Perigo, W. H. Briggs, K. T. Landschulz, T. G. Turi, J. F. Thompson, P. Libby, and T. N. Wight
Mechanical Strain Induces Specific Changes in the Synthesis and Organization of Proteoglycans by Vascular Smooth Muscle Cells
J. Biol. Chem., April 20, 2001; 276(17): 13847 - 13851.
[Abstract] [Full Text] [PDF]